Development of an LC-MS/MS method for the quantitation of 55 compounds prescribed in combined cardiovascular therapy

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 879, Issue 3-4, 2011, Pages 243-252

  Gonzalez, Oskar ^a   Alonso, Rosa Maria ^a   Ferreirós, Nerea ^b   Weinmann, Wolfgang ^c   Zimmermann, Ralf ^d,e   Dresen, Sebastian ^d,f  

^a Analytical Chemistry Department   (Spain)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF ROSTOCK   (Germany)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

^f UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cardiovascular drugs; LC MS MS; Matrix effect; Metabolic syndrome

Indexed keywords

ACCURACY AND PRECISION; ANALYTES; ANTIDIABETIC; CARDIOVASCULAR DRUGS; GRADIENT ELUTION; HUMAN PLASMAS; INTERNAL STANDARDS; LC-MS/MS; LIMITS OF DETECTION; LIMITS OF QUANTITATIONS; MATRIX EFFECTS; METABOLIC SYNDROMES; PLASMA SAMPLES; POSITIVE ELECTROSPRAY IONIZATION; PROTEIN PRECIPITATION; QUANTITATIVE ANALYSIS; QUANTITATIVE RESULT; SAMPLE TREATMENT;

ELECTROSPRAY IONIZATION; METABOLISM;

CHEMICAL ANALYSIS;

ACEBUTOLOL; AMLODIPINE; ATENOLOL; ATORVASTATIN; BEFUNOLOL; BISOPROLOL; CANDESARTAN; CARDIOVASCULAR AGENT; ENALAPRIL; ENALAPRILAT; ESMOLOL; FELODIPINE; FLUINDOSTATIN; GLIBENCLAMIDE; IRBESARTAN; LERCANIDIPINE; LISINOPRIL; METFORMIN; METOPROLOL; NICARDIPINE; PENBUTOLOL; PERINDOPRIL; QUINAPRILAT; RAMIPRIL; REPAGLINIDE; SIMVASTATIN; TICLOPIDINE; UNINDEXED DRUG; VALSARTAN; WARFARIN;

ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; DRUG BLOOD LEVEL; ELECTROSPRAY MASS SPECTROMETRY; EVAPORATION; HUMAN; LIQUID CHROMATOGRAPHY; PRECIPITATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY;

CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CHROMATOGRAPHY, LIQUID; DRUG MONITORING; DRUG THERAPY, COMBINATION; HEMATOLOGIC AGENTS; HUMANS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; LEAST-SQUARES ANALYSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

EID: 78751706093     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2010.12.007     Document Type: Article

References (30)

1. Grundy S.M., Brewer H.B., Cleeman J.I., Smith S.C., Lenfant C. Circulation 2004, 109:433.
2. Alberti K.G., Zimmet P., Shaw J. Lancet 2005, 366:1059.
3. Grundy S.M. Arterioscler. Thromb. Vasc. Biol. 2008, 28:629.
4. W.H. Organization, (October 2010). http://www.who.int/cardiovascular_diseases/en/.
5. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., Gordon D.J., Krauss R.M., Savage P.J., Smith S.C., Spertus J.A., Costa F. Circulation 2005, 112:2735.
6. Marcus A.O. Diabetes Technol. Ther. 2000, 2:101.
7. Marcus A.O. Diabetes Technol. Ther. 2000, 2:275.
8. Grassin Delyle S., Duverneuil-Mayer C., Abe E., Mathieu B., Lorin De La Grandmaison G., Charlier P., Alvarez J.C. Forensic Sci. Int. 2008, 178:e19.
9. Murray G.J., Danaceau J.P. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2009, 877:3857.
10. Sklerov J.H., Levine B., Ingwersen K.M., Aronica-Pollack P.A., Fowler D. J. Anal. Toxicol. 2006, 30:346.
11. Vets E., Rossignol J.F., Jackson A.S. Am. J. Health Syst. Pharm. 2009, 66:838.
12. Williams D., Feely J. Clin. Pharmacokinet. 2002, 41:343.
13. Molden E., Andersson K.S. Pharmacotherapy 2007, 27:603.
14. Dresen S., Ferreiros N., Gnann H., Zimmermann R., Weinmann W. Anal. Bioanal. Chem. 2010, 396:2425.
15. V. Viette, D. Guillarme, R. Mylonas, Y. Mauron, M. Fathi, S. Rudaz, D. Hochstrasser, J.L. Veuthey, Clin. Biochem., doi:10.1016/j.clinbiochem.2010.1007.1021.
16. V. Viette, D. Guillarme, R. Mylonas, Y. Mauron, M. Fathi, S. Rudaz, D. Hochstrasser, J.L. Veuthey, Clin. Biochem., doi:10.1016/j.clinbiochem.2010.1007.1019.
17. Aburuz S., Millership J., McElnay J. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2005, 817:277.
18. Gonzalez O., Iriarte G., Rico E., Ferreiros N., Maguregui M.I., Alonso R.M., Jimenez R.M. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2010, 878:2685.
19. Kristoffersen L., Oiestad E.L., Opdal M.S., Krogh M., Lundanes E., Christophersen A.S. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 850:147.
20. Tutunji M.F., Ibrahim H.M., Khabbas M.H., Tutunji L.F. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2009, 877:1689.
21. Ferreiros N., Dresen S., Alonso R.M., Weinmann W. Ther. Drug Monit. 2007, 29:824.
22. Vogeser M., Seger C. Clin. Biochem. 2008, 41:649.
23. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Anal. Chem. 2003, 75:3019.
24. Bonfiglio R., King R.C., Olah T.V., Merkle K. Rapid Commun. Mass Spectrom. 1999, 13:1175.
25. ICH, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Validation of analytical procedures: text and methodology Q2(R1), 2005.
26. Almeida A.M., Castel-Branco M.M., Falcao A.C. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2002, 774:215.
27. Chambers E., Wagrowski-Diehl D.M., Lu Z., Mazzeo J.R. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 852:22.
28. Shen J.X., Motyka R.J., Roach J.P., Hayes R.N. J. Pharm. Biomed. Anal. 2005, 37:359.
29. Annesley T.M. Clin. Chem. 2003, 49:1041.
30. Baranda A.B., Alonso R.M., Jimenez R.M., Weinmann W. Forensic Sci. Int. 2006, 156:23.